Google Employee Charged in 1 Million Polymarket Insider Trading Bet
USCIS Updates Green Card Process Applicants Now Required to Return Home for Filing
Caribbean Islanders Raise Concerns Over Foreign Developer Land Acquisitions Restricting Beach Access
GP Petroleums Reports 8 Profit Increase in Q4 Amid Revenue Decline
Federal Reserve Rate Cut Outlook Dims After Strong Jobs Report
Wholesale Inflation Surges 6 Annually in April Marking Sharpest Rise Since 2022
Scienjoy Holding Corporation SJ Q1 2025 Earnings Net Loss Reported Amid Limited Disclosures
BMA Q4 2025 Earnings Strong EPS Beat Amidst Mixed Market Reaction
INNOVATE Corp VATE Q1 2026 Earnings Hefty Loss Amid Operational Challenges Stock Declines
Entera Bio ENTX Q1 2026 Earnings Narrowing Losses as Cash Burn Remains in Focus
KOD Q1 2026 Earnings Narrower Loss on Lower Spending as Pipeline Progress Continues
SYY Q1 2026 Earnings EPS Miss Slightly as Cost Pressures Weigh
Hub Cyber Security HUBC Faces Continued Pressure Testing Key Support Levels
Satellos Bioscience MSLE Surges 7 as Biotech Stock Breaks Above Key Support
Autolus Therapeutics AUTL Holds Steady Near Support as Biotech Sector Watches
Viking Therapeutics VKTX Edges Higher as Stock Approaches Resistance
Revelation Biosciences REVB Faces Slight Decline as Key Support Levels Are Tested
Treasury Yield Surge Prompts Bond Investors to Seek Alternative FixedIncome Opportunities
ZENA Q4 2025 Earnings Massive EPS Miss Without Revenue Disclosure as Stock Surges 511
ASE Technology Holding ASX Surges 665 Nears Key Resistance at 3655
Primoris Services Corporation PRIM Q1 2026 Earnings EPS Misses Estimates Stock Gains on Operational Confidence
BMBL Q1 2026 Earnings EPS Beat Drives Slight Stock Uptick as User Trends Remain in Focus
PEG Q1 2026 Earnings Utility Giant Beats Estimates as Operational Efficiency Drives Profit
NEGG Q4 2022 Earnings Sharp EPS Miss Overshadows Modest Stock Uptick
PFE Q1 2026 Earnings EPS Beats Estimates Amid Revenue Disclosure Gap
Textron TXT Q1 2026 Earnings EPS Surpasses Estimates by 101 Revenue Details Unavailable
ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline